Regine Audran
Lausanne, VD, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland.
Journal: BMC infectious diseases
Published: October 21, 2024
Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route.
Journal: The Journal of infection
Published: March 27, 2024
Immunomodulation profile of the biosimilar trastuzumab MYL-1401O in a bioequivalence phase I study.
Journal: Scientific reports
Published: June 05, 2023
P. falciparum and P. vivax Orthologous Coiled-Coil Candidates for a Potential Cross-Protective Vaccine.
Journal: Frontiers in immunology
Published: June 19, 2020
Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A.
Journal: Frontiers in immunology
Published: December 03, 2019
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy.
Journal: Oncoimmunology
Published: July 09, 2019
The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes.
Journal: The Journal of experimental medicine
Published: February 17, 2019
Novel Nanofluidic IgE Assay versus a Reference Method: A Real-World Comparison.
Journal: International archives of allergy and immunology
Published: January 24, 2019
Supplemental parenteral nutrition improves immunity with unchanged carbohydrate and protein metabolism in critically ill patients: The SPN2 randomized tracer study.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: October 29, 2018
The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 19, 2018
Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis.
Journal: Nature communications
Published: November 22, 2016
Last Updated: 09/26/2026